Amplify Surgical
Private Company
Total funding raised: $15M
Overview
Founded in 2014, Amplify Surgical is a medical technology company dedicated to transforming spine surgery through minimally invasive and endoscopic solutions. Its mission is to improve patient safety and outcomes by providing surgeons with groundbreaking tools like the dualPortal® endoscopic system and dualX® expandable interbody implants. The company leverages a seasoned leadership team with deep experience in spinal device development and commercialization, having previously contributed to major platforms at companies like Stryker and Alphatec Spine. Amplify Surgical operates as a private, commercial-stage company, focusing on surgeon education and adoption of its novel techniques.
Technology Platform
An integrated platform featuring the dualPortal® two-portal endoscopic surgical approach for spine access and the dualX® family of expandable interbody implants designed for minimally invasive and endoscopic lumbar fusion procedures.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Amplify Surgical competes against major spinal device companies like Medtronic, Stryker, and Johnson & Johnson, as well as pure-play spine firms like Globus Medical and Alphatec Spine. Its key differentiation is the synergistic dualPortal® two-portal endoscopic technique and the dualX® Slim expandable cage designed specifically for it, offering a potentially superior solution for endoscopic lumbar fusion compared to single-portal systems.